Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Journal of Nuclear Medicine October 2024, jnumed.124.268277; DOI: https://doi.org/10.2967/jnumed.124.268277 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268796; DOI: https://doi.org/10.2967/jnumed.124.268796 You do not have access to the full text of this article ...

Journal of Nuclear Medicine October 2024, jnumed.124.268386; DOI: https://doi.org/10.2967/jnumed.124.268386 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Journal of Nuclear Medicine October 2024, jnumed.123.267238; DOI: https://doi.org/10.2967/jnumed.123.267238 Although radiopharmaceutical cocktails targeting different ...

Journal of Nuclear Medicine October 2024, jnumed.124.268254; DOI: https://doi.org/10.2967/jnumed.124.268254 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Journal of Nuclear Medicine October 2024, jnumed.124.268443; DOI: https://doi.org/10.2967/jnumed.124.268443 ...

Journal of Nuclear Medicine October 2024, jnumed.124.268037; DOI: https://doi.org/10.2967/jnumed.124.268037 ...

The cost of “1 size fits all”: Stabin provides perspective as both a cancer survivor and nuclear medicine professional on the importance of patient-individualized approaches to radiopharmaceutical ...